Archive - Bio Signal

Betting Big on Bispecifics

The Next Wave of Bispecific Antibodies & Antibody‑Mediated Vaccines

Aug 29 •

Immune Cartography Meets Therapeutic Engineering

Turning spatial AI insights into rationally designed biologics that orchestrate immunity

Aug 9 •

July 2025

The Immunity Butterfly Effect

How spatial biology and causal AI are redefining drug discovery

Jul 23 •

How Human-Centric R&D Is Redefining Drug Discovery

Turning human data into breakthrough drugs

Jul 2 •

June 2025

Why Longevity Starts with Rebooting Your Defenses

The most powerful anti-aging therapy might not be a gene hack, but restoring the immune conversations that keep us alive.

Jun 20 •

The T Cell Fountain of Youth

Rewriting the rules of tumor control by preserving the immune reservoir

Jun 14 •

Why Pan-Cancer Immunotherapy Is a Biotech Goldmine

How tissue-agnostic therapies are expanding markets, accelerating approvals, and lowering risk across oncology portfolios

Jun 8 •

Building the Future of Immunotherapy

Why durable responses in solid tumors demand immune coordination

Jun 2 •

May 2025

The Allure and Limits of “H&E → Transcriptome” Models

Why Tissue Imaging Must Move Beyond Predicting What’s Already Known

May 29 •

Trading Animal Models for Patient-Derived Precision

Can Human Tumor Fragments Replace Mouse Studies?

May 26 •

May 2024

Getting more from multimodal omics

Unlocking the full potential of multimodal omics data to get the highest return on investment.

May 18, 2024 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts